On Sept. 7, 2021, Takeda Pharmaceutical announced the Government of Japan’s Ministry of Health, Labour and Welfare purchase…
On Sept. 3, 2021, Moderna announced that it had submitted for a conditional marketing approval (CMA) with the…
On Sept. 1, 2021, Moderna announced it had initiated its submission to the U.S. Food and Drug Administration…
On Aug. 30, 2021, the Mayo Clinic reported that in an observational study the combination of casirivimab and…
On Aug. 26, 2021, Oregon Health & Science University (OHSU) announced a laboratory study from found that blood…
On Aug. 25, 2021, Anixa Biosciences announced that a genomic variant analysis indicateed that its potential compounds may…
On Aug. 25, 2021, Moderna announced it had completed the rolling submission process for its Biologics License Application…
On Aug. 19, 2021, the University of Oxford reported that obtaining two vaccine doses remained the most effective…
On Aug. 16, 2021, Moderna announced a revised supply agreement with the Government of Canada for up to…
On Aug. 13, 2021, Moderna announced that the Food and Drug Administration (FDA) had approved an update to…
On Aug. 12, 2021, the U.S. Department of Veterans Affairs (VA) announced that it expanded his previous COVID-19…
On Aug. 12, 2021, Moderna announced the publication of new data on the durability of the Moderna COVID-19…
On Aug. 12, 2021, Innovation Pharma released information regarding the status of its randomized, double-blind, placebo-controlled Phase 2…
On Aug. 10, 2021, the National Institutes of Health (NIH) announced that a pilot study had begun to…
On Aug. 10, 2021, Moderna announced a Memorandum of Understanding (MoU) with the government of Canada to build…
On Aug. 9, 2021, Moderna announced that the Therapeutic Goods Administration (TGA) had granted provisional registration to the…
On Aug. 9, 2021, Inovio Pharma announced that it had received regulatory allowance for two clinical trials investigating…
On Aug. 5, 2021, Novavax announced preliminary data demonstrating that a single booster dose of its recombinant nanoparticle…
On Aug. 4, 2021, Novavax announced that it had reached an agreement with the European Commission (EC) for…
On Aug. 3, 2021, Moderna announced that the U.S. Food and Drug Administration (FDA) had granted Fast Track…
On Aug. 3, 2021, CytoDyn announced that Brazil’s regulatory authority ANVISA (Agência Nacional de Vigilância Sanitária) has approved…
On Jul. 29, 2021, Vaxart announced that it has shown for the first time in clinical trials that…
On Jul. 28, 2021, GlaxoSmithKline and Vir Biotechnology announced they had signed a Joint Procurement Agreement with the…
On Jul. 27, 2021, Oragenics announced it had entered into a licensing agreement with the National Research Council…
On Jul. 23, 2021, Moderna announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human…
On Jul. 22, 2021, Moderna announced a new supply agreement with Taiwan for 20 million doses of Moderna’s…
On Jul. 20, 2021, Moderna announced that the Ministry of Health, Labour and Welfare of Japan (MHLW) and…
On Jul. 12, 2021, Moderna announced a supply agreement with the government of Argentina for 20 million doses…
On Jul. 1, 2021, Moderna confirmed that following the European Medicines Agency’s (EMA) Committee for Human Medicines (CHMP)…
On Jun. 30, 2021, Novavax announced the publication of results from the final analysis of a pivotal Phase…